Efficacy and safety of switching etanercept to an anti-TNF monoclonal antibody in patients with juvenile idiopathic arthritis.

被引:0
|
作者
Russo, Ricardo A. [1 ]
Katsicas, Maria M. [1 ]
机构
[1] Hosp Pediat, Buenos Aires, DF, Argentina
来源
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S681 / S682
页数:2
相关论文
共 50 条
  • [21] SAFETY AND EFFICACY OF ETANERCEPT IN JUVENILE IDIOPATHIC ARTHRITIS PATIENTS UNDER TWO YEARS OF AGE
    Horneff, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 430 - 431
  • [22] EFFICACY AND SAFETY OF ETANERCEPT IN COMBINATION WITH METHOTREXATE IN THE PATIENTS WITH EARLY AND LATE JUVENILE IDIOPATHIC ARTHRITIS
    Alekseeva, E.
    Bzarova, T.
    Fetisova, A.
    Valieva, S.
    Isayeva, K.
    Denisova, R.
    Sleptsova, T.
    Mitenko, E.
    Chistyakova, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 736 - 736
  • [23] The Efficacy Of Etanercept In Patients With Juvenile Idiopathic Arthritis With Inadequate Response To Infliximab As a First TNF Inhibitor
    Alekseeva, Ekaterina
    Bzarova, Tatyana
    Fetisova, Anna
    Sleptsova, Tatyana
    Valieva, Saniya
    Isayeva, Kseniya
    Denisova, Rina
    Mitenko, Elena
    Chistyakova, Evgeniya
    Taybulatov, Nikolay
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S123 - S124
  • [24] Sustained response to etanercept in systemic juvenile idiopathic arthritis.
    Russo, RAG
    Katsicas, MM
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S93 - S93
  • [25] The German etanercept registry for treatment of juvenile idiopathic arthritis.
    Horneff, G
    Biedermann, T
    Foeldvari, I
    Kuesters, RM
    Michels, H
    Moebius, D
    Schmeling, H
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S482 - S482
  • [26] Tuberculin skin test response in patients with juvenile idiopathic arthritis on anti-TNF therapy
    Barut, Kenan
    Sahin, Sezgin
    Adrovic, Amra
    Kosker, Muhammet
    Kilic, Omer
    Camcioglu, Yildiz
    Cokugras, Haluk
    Akcakaya, Necla
    Sozeri, Betul
    Kasapcopur, Ozgur
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2018, 48 (06) : 1109 - 1114
  • [27] Adverse events during anti-TNF therapy in 269 patients with juvenile idiopathic arthritis
    M Tarkiainen
    P Tynjälä
    P Vähäsalo
    P Lahdenne
    Pediatric Rheumatology, 6 (Suppl 1)
  • [28] ADVERSE EVENTS DURING ANTI-TNF THERAPY IN 292 PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
    Tarkiainen, M.
    Vahasalo, P.
    Tynjala, P.
    Lahdenne, P.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2009, 38 (05) : 402 - 403
  • [29] The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis
    SA Alfantaki
    S Stavrou
    A Siamopoulou-Mavridou
    Pediatric Rheumatology, 9 (Suppl 1)
  • [30] Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
    Imagawa, Tomoyuki
    Yokota, Shumpei
    Mori, Masaaki
    Miyamae, Takako
    Takei, Syuji
    Imanaka, Hiroyuki
    Nerome, Yasuhito
    Iwata, Naomi
    Murata, Takuji
    Miyoshi, Mari
    Nishimoto, Norihiro
    Kishimoto, Tadamitsu
    MODERN RHEUMATOLOGY, 2012, 22 (01) : 109 - 115